From Bench to Bedside: How the Tumor Microenvironment Is Impacting the Future of Immunotherapy for Renal Cell Carcinoma

Immunotherapy has revolutionized the treatment landscape for many cancer types. The treatment for renal cell carcinoma (RCC) has especially evolved in recent years, from cytokine-based immunotherapies to immune checkpoint inhibitors. Although clinical benefit from immunotherapy is limited to a subse...

Full description

Saved in:
Bibliographic Details
Main Authors: Jonathan Anker, Justin Miller, Nicole Taylor, Natasha Kyprianou, Che-Kai Tsao
Format: article
Language:EN
Published: MDPI AG 2021
Subjects:
Online Access:https://doaj.org/article/951e1e7f7a2f46bbb26efa30f2a3f187
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items